Literature DB >> 19484745

Under-reporting of compensable mesothelioma in Alberta.

Marilyn W Cree1, Munira Lalji, Bei Jiang, Keumhee C Carriere.   

Abstract

BACKGROUND: When combined with a history of occupational asbestos exposure, mesothelioma is often presumed work-related. In Canada, workers diagnosed with mesothelioma caused by occupational asbestos exposure are often eligible for compensation under provincial workers' compensation boards. Although occupational asbestos exposure causes the majority of mesothelioma, Canadian research suggests less than half of workers actually apply for compensation. Alberta's mandatory reporting requirements may produce higher filing rates but this is currently unknown. This study evaluates Alberta's mesothelioma filing and compensation rates.
METHODS: Demographic information on all mesothelioma patients diagnosed between 1980 and 2004 were extracted from the Alberta Cancer Board's Cancer Registry and linked to Workers' Compensation Board of Alberta claims data.
RESULTS: Alberta recorded a total of 568 histologically confirmed mesothelioma cases between 1980 and 2004. Forty-two percent of cases filed a claim; 83% of filed claims were accepted for compensation.
CONCLUSIONS: Patient under-reporting of compensable mesothelioma is a problem and raises larger questions regarding under-reporting of other asbestos-related cancers in Alberta. Strategies should focus on increasing filing rates where appropriate.

Entities:  

Mesh:

Year:  2009        PMID: 19484745     DOI: 10.1002/ajim.20705

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  2 in total

1.  Pleural mesothelioma surveillance: validity of cases from a tumour registry.

Authors:  France Labrèche; Bruce W Case; Gaston Ostiguy; Jean Chalaoui; Michel Camus; Jack Siemiatycki
Journal:  Can Respir J       Date:  2012 Mar-Apr       Impact factor: 2.409

2.  Trends in compensation for deaths from occupational cancer in Canada: a descriptive study.

Authors:  Ann Del Bianco; Paul A Demers
Journal:  CMAJ Open       Date:  2013-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.